Skip to content

magnesium sulphate for extending labor epidural analgesia for emergency cesarean section:

Anesthetic conversion of preexisting labor epidural analgesia for emergency cesarean section: Efficacy of levopubivacaine with or without magnesium sulphate. A prospective randomized study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202007634121137
Enrollment
50
Registered
2020-07-30
Start date
2020-08-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

group I epidural levopubivacaine
group II epidural levopubivacaine with magnesium sulphate

Sponsors

Dr Tamer Mohamed Naguib
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: parturients who were in active labor (gestational age>37 weeks) aged 18–35 years old, had an American Society of Anesthesiologists status II admitted for an emergency CS after an established labor epidural analgesia.

Exclusion criteria

Exclusion criteria: an emergency CS of the first type multiple pregnancies a high-risk pregnancy (e.g. preeclampsia, antepartum hemorrhage, diabetes mellitus, body mass index (BMI) =35 kg/m2) a malfunctioning epidural catheter during the labor( no analgesia after two intra-partum top-up doses) last labor epidural supplementation of less than two hours, hemodynamic instability after a previous top-up documented history of allergy to any of the drugs used in the trial.

Design outcomes

Primary

MeasureTime frame
onset of the block

Secondary

MeasureTime frame
Duration of labor analgesia ;Time since last top-up dose ;pre sensory and motor level and pain score;Time to block at level T6 ;Number of patients who needed top-up to reach level T6.;sensory and motor block at start of surgery;Number of patients needed Supplemental intraoperative analgesia;duration of analgesia;time to motor recovery;Apgar score;adverse events e.g. hypotension, bradycardia, somnolence

Countries

Egypt

Contacts

Public ContactMona El ghamry

Lecturer of Anesthesia and Surgical Intensive Care Faculty of Medicine Tanta University

drmonagh19802000@gmail.com00201060101867

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026